China’s Tech Giants Race Into AI Pharma With Five Distinct Playbooks
ByteDance's spinoff of its AI pharma unit on June 10 crystallized a defining shift: China's largest internet platforms are no longer circling the drug discovery industry from the outside — they are restructuring their core businesses around it, each deploying a strategically distinct playbook that reveals as